Trevi Therapeutics (TRVI) Depreciation and Depletion (2018 - 2022)
Trevi Therapeutics' quarterly Depreciation and Depletion came in at $15000.0 in Q4 2022, up 25.0% year-on-year from $12000.0 in Q4 2021, and up 66.67% quarter-over-quarter from $9000.0 in Q3 2022.
Trevi Therapeutics has reported Depreciation and Depletion for 5 years, with the latest figure at $15000.0 in Q4 2022.
- For the quarter ending Q4 2022, Depreciation and Depletion rose 25.0% year-over-year to $15000.0; the trailing twelve-month figure through Dec 2022 stood at $43000.0 (down 14.0% YoY), and the FY2025 full-year result was $132000.0, up 40.43% from the prior year.
- Depreciation and Depletion for Q4 2022 stood at $15000.0, up from $9000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $15000.0 in Q4 2022, with the low at $2000.0 in Q1 2018.
- Average Depreciation and Depletion over 5 years is $10100.0, with a median of $11000.0 recorded in 2019.
- Year-over-year, Depreciation and Depletion jumped 350.0% in 2019 and sank 33.33% in 2022.
- Tracing TRVI's Depreciation and Depletion over 5 years: stood at $13000.0 in 2018, then tumbled by 30.77% to $9000.0 in 2019, then jumped by 44.44% to $13000.0 in 2020, then declined by 7.69% to $12000.0 in 2021, then increased by 25.0% to $15000.0 in 2022.
- The last three Depreciation and Depletion figures came in at $15000.0 (Q4 2022), $9000.0 (Q3 2022), and $8000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 15,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 11,000.00 |
| Sep 30, 2019 | 11,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Dec 31, 2018 | 13,000.00 |
| Dec 31, 2018 | 13,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Mar 31, 2018 | 2,000.00 |